Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05730712
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2023-02-07
Brief Title:
Pertuzumab Trastuzumab Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IVB Prostate Cancer AJCC v8 |
| Castration-Resistant Prostate Carcinoma |
Keywords: